{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:23:50Z","timestamp":1753889030429,"version":"3.41.2"},"reference-count":36,"publisher":"Archives of Endocrinology and Metabolism","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,21]]},"DOI":"10.20945\/2359-3997000000649","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T13:00:01Z","timestamp":1687784401000},"source":"Crossref","is-referenced-by-count":2,"title":["Is elevated blood glucose at admission associated with poor outcomes in hospitalized COVID-19 patients?"],"prefix":"10.20945","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8604-6477","authenticated-orcid":false,"given":"Mariana","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2193-1739","authenticated-orcid":false,"given":"Juliana","family":"Marques-S\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-745X","authenticated-orcid":false,"given":"Carla","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-3867","authenticated-orcid":false,"given":"Vera","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"key":"key20230626085957_B1","author":"WHO","year":"2020","unstructured":"1 WHO. WHO Director-General\u2019s opening remarks at the media briefing on COVID-19. 11 March 2020 (2020). Available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020","journal-title":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19"},{"issue":"18","key":"key20230626085957_B2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","unstructured":"2 Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.","journal-title":"N Engl J Med"},{"issue":"10229","key":"key20230626085957_B3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","unstructured":"3 Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.","journal-title":"Lancet"},{"issue":"6","key":"key20230626085957_B4","doi-asserted-by":"crossref","first-page":"1068.e3","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes","volume":"31","author":"Zhu","year":"2020","unstructured":"4 Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. (Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020;31(6):1068-77.e3.","journal-title":"Cell Metab"},{"issue":"1","key":"key20230626085957_B5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001343","article-title":"Clinical characteristics and outcomes of patients with severe covid-19 with diabetes","volume":"8","author":"Yan","year":"2020","unstructured":"5 Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, et al. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care. 2020;8(1):e001343.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"7","key":"key20230626085957_B6","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","volume":"36","author":"Guo","year":"2020","unstructured":"6 Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36(7):e3319.","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"key20230626085957_B7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1932296820924469","article-title":"Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States","volume":"14","author":"Bode","year":"2020","unstructured":"7 Bode B, Garrett V, Messler J, McFarland R, Crowe J, Booth R, et al. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Diabetes Sci Technol. 2020;14(4):813-21.","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"key20230626085957_B8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diabet.2020.05.001","article-title":"Patients with diabetes are at higher risk for severe illness from COVID-19","volume":"46","author":"Targher","year":"2020","unstructured":"8 Targher G, Mantovani A, Wang XB, Yan HD, Sun QF, Pan KH, et al. Patients with diabetes are at higher risk for severe illness from COVID-19. Diabetes Metab. 2020;46(4):335-7.","journal-title":"Diabetes Metab"},{"issue":"5","key":"key20230626085957_B9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00134-004-2167-y","article-title":"Stress-hyperglycemia, insulin and immunomodulation in sepsis","volume":"30","author":"Marik","year":"2004","unstructured":"9 Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30(5):748-56.","journal-title":"Intensive Care Med"},{"issue":"1","key":"key20230626085957_B10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001476","article-title":"Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study","volume":"8","author":"Wu","year":"2020","unstructured":"10 Wu J, Huang J, Zhu G, Wang Q, Lv Q, Huang Y, et al. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study. BMJ Open Diabetes Res Care. 2020;8(1):e001476.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"key20230626085957_B11","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/jmv.26608","article-title":"Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19","volume":"93","author":"Yang","year":"2021","unstructured":"11 Yang P, Wang N, Wang J, Luo A, Gao F, Tu Y. Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19. J Med Virol. 2021;93(4):2168-76.","journal-title":"J Med Virol"},{"key":"key20230626085957_B12","doi-asserted-by":"crossref","first-page":"108374","DOI":"10.1016\/j.diabres.2020.108374","article-title":"Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration","volume":"168","author":"Fadini","year":"2020","unstructured":"12 Fadini GP, Morieri ML, Boscari F, Fioretto P, Maran A, Busetto L, et al. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diabetes Res Clin Pract. 2020;168:108374.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"key20230626085957_B13","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s42399-020-00575-8","article-title":"Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature","volume":"2","author":"Sachdeva","year":"2020","unstructured":"13 Sachdeva S, Desai R, Gupta U, Prakash A, Jain A, Aggarwal A. Admission Hyperglycemia in Non-diabetics Predicts Mortality and Disease Severity in COVID-19: a Pooled Analysis and Meta-summary of Literature. SN Compr Clin Med. 2020;2(11):2161-6.","journal-title":"SN Compr Clin Med"},{"key":"key20230626085957_B14","doi-asserted-by":"crossref","first-page":"m1198","DOI":"10.1136\/bmj.m1198","article-title":"Covid-19: risk factors for severe disease and death","volume":"368","author":"Jordan","year":"2020","unstructured":"14 Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198.","journal-title":"BMJ"},{"issue":"11","key":"key20230626085957_B15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","unstructured":"15 Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.","journal-title":"JAMA"},{"issue":"9","key":"key20230626085957_B16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/CM9.0000000000000819","volume":"133","author":"Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)","year":"2020","unstructured":"16 Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin Med J (Engl). 2020;133(9):1087-95.","journal-title":"Chin Med J (Engl)"},{"issue":"3 Pt 1","key":"key20230626085957_B17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","unstructured":"17 Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 Pt 1):818-24.","journal-title":"Am J Respir Crit Care Med"},{"key":"key20230626085957_B18","volume-title":"Recomenda\u00e7\u00f5es Conjuntas da Sociedade Portuguesa de Diabetologia (SPD)\/Sociedade Portuguesa de Medicina Interna (SPMI) sobre a Abordagem e Tratamento da Hiperglicemia em Internamento (n\u00e3o Cr\u00edtico) Joint Recommendations of the Portuguese Diabetology Society (SPD)\/Portuguese Internal Medicine Society (SPMI) on the Management and Treatment of Hyperglycemia in Non Critical Hospital Inpatients","author":"Godinho","year":"2016","unstructured":"18 Godinho C, Jord\u00e3o A, Dias A, Lopes A, Duarte A, Carvalho D, et al. Recomenda\u00e7\u00f5es Conjuntas da Sociedade Portuguesa de Diabetologia (SPD)\/Sociedade Portuguesa de Medicina Interna (SPMI) sobre a Abordagem e Tratamento da Hiperglicemia em Internamento (n\u00e3o Cr\u00edtico) Joint Recommendations of the Portuguese Diabetology Society (SPD)\/Portuguese Internal Medicine Society (SPMI) on the Management and Treatment of Hyperglycemia in Non Critical Hospital Inpatients. Lisboa: SPD, SPMI; 2016."},{"key":"key20230626085957_B19","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268820001430","article-title":"Epidemiological characteristics of COVID-19: a systematic review and meta-analysis","volume":"148","author":"Khalili","year":"2020","unstructured":"19 Khalili M, Karamouzian M, Nasiri N, Javadi S, Mirzazadeh A, Sharifi H. Epidemiological characteristics of COVID-19: a systematic review and meta-analysis. Epidemiol Infect. 2020;148:e130.","journal-title":"Epidemiol Infect"},{"issue":"9677","key":"key20230626085957_B20","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","article-title":"Stress hyperglycaemia","volume":"373","author":"Dungan","year":"2009","unstructured":"20 Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798-807.","journal-title":"Lancet"},{"issue":"3","key":"key20230626085957_B21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"Umpierrez","year":"2002","unstructured":"21 Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-82.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20230626085957_B22","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","unstructured":"22 Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ, Wu BY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23(6):623-8.","journal-title":"Diabet Med"},{"issue":"10","key":"key20230626085957_B23","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2337\/dc20-1380","article-title":"Hyperglycemia at Hospital Admission Is Associated with Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study","volume":"43","author":"Coppelli","year":"2020","unstructured":"23 Coppelli A, Giannarelli R, Aragona M, Penno G, Falcone M, Tiseo G, et al. Hyperglycemia at Hospital Admission Is Associated with Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study. Diabetes Care. 2020;43(10):2345-8.","journal-title":"Diabetes Care"},{"key":"key20230626085957_B24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3389\/fendo.2020.00525","article-title":"Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients with Coronavirus Disease 2019","volume":"11","author":"Zhang","year":"2020","unstructured":"24 Zhang J, Kong W, Xia P, Xu Y, Li L, Li Q, et al. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients with Coronavirus Disease 2019. Front Endocrinol (Lausanne). 2020;11:525.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"key20230626085957_B25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/07853890.2020.1836566","article-title":"Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry","volume":"53","author":"Carrasco-S\u00e1nchez","year":"2021","unstructured":"25 Carrasco-S\u00e1nchez FJ, L\u00f3pez-Carmona MD, Mart\u00ednez-Marcos FJ, P\u00e9rez-Belmonte LM, Hidalgo-Jim\u00e9nez A, Buonaiuto V, et al. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry. Ann Med. 2021;53(1):103-16.","journal-title":"Ann Med"},{"issue":"2","key":"key20230626085957_B26","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203584","article-title":"Hyperglycemia at admission is a strong predictor of mortality and severe\/critical complications in COVID-19 patients: a meta-analysis","volume":"41","author":"Yang","year":"2021","unstructured":"26 Yang Y, Cai Z, Zhang J. Hyperglycemia at admission is a strong predictor of mortality and severe\/critical complications in COVID-19 patients: a meta-analysis. Biosci Rep. 2021;41(2).","journal-title":"Biosci Rep"},{"issue":"7","key":"key20230626085957_B27","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072199","article-title":"Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients","volume":"13","author":"Charoenngam","year":"2021","unstructured":"27 Charoenngam N, Alexanian SM, Apovian CM, Holick MF. Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients. Nutrients. 2021;13(7).","journal-title":"Nutrients"},{"key":"key20230626085957_B28","doi-asserted-by":"crossref","first-page":"108561","DOI":"10.1016\/j.diabres.2020.108561","article-title":"High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis","volume":"171","author":"Lazarus","year":"2021","unstructured":"28 Lazarus G, Audrey J, Wangsaputra VK, Tamara A, Tahapary DL. High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis. Diabetes Res Clin Pract. 2021;171:108561.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"key20230626085957_B29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","article-title":"The Effect of Short-Term Hyperglycemia on the Innate Immune System","volume":"351","author":"Jafar","year":"2016","unstructured":"29 Jafar N, Edriss H, Nugent K. The Effect of Short-Term Hyperglycemia on the Innate Immune System. Am J Med Sci. 2016;351(2):201-11.","journal-title":"Am J Med Sci"},{"issue":"7","key":"key20230626085957_B30","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/jmv.25887","article-title":"Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic","volume":"92","author":"Brufsky","year":"2020","unstructured":"30 Brufsky A. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. J Med Virol. 2020;92(7):770-5.","journal-title":"J Med Virol"},{"issue":"1","key":"key20230626085957_B31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","unstructured":"31 Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45.","journal-title":"Infect Dis Poverty"},{"issue":"5","key":"key20230626085957_B32","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/jmv.26677","article-title":"Obesity aggravates COVID-19: An updated systematic review and meta-analysis","volume":"93","author":"Yang","year":"2021","unstructured":"32 Yang J, Tian C, Chen Y, Zhu C, Chi H, Li J. Obesity aggravates COVID-19: An updated systematic review and meta-analysis. J Med Virol. 2021;93(5):2662-74.","journal-title":"J Med Virol"},{"key":"key20230626085957_B33","doi-asserted-by":"crossref","first-page":"154378","DOI":"10.1016\/j.metabol.2020.154378","article-title":"Obesity in patients with COVID-19: a systematic review and meta-analysis","volume":"113","author":"Huang","year":"2020","unstructured":"33 Huang Y, Lu Y, Huang YM, Wang M, Ling W, Sui Y, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism. 2020;113:154378.","journal-title":"Metabolism"},{"issue":"2","key":"key20230626085957_B34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.20344\/amp.15423","article-title":"Obesity and COVID-19: A Forgotten Relationship","volume":"34","author":"Barbosa","year":"2021","unstructured":"34 Barbosa M, Lopes S, Fernandes V, Monteiro AM. Obesity and COVID-19: A Forgotten Relationship. Acta Med Port. 2021;34(2):161.","journal-title":"Acta Med Port"},{"issue":"11","key":"key20230626085957_B35","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s00125-020-05216-2","article-title":"Hyperglycaemia on admission to hospital and COVID-19","volume":"63","author":"Sardu","year":"2020","unstructured":"35 Sardu C, D\u2019Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. Hyperglycaemia on admission to hospital and COVID-19. Diabetologia. 2020;63(11):2486-7.","journal-title":"Diabetologia"},{"issue":"7","key":"key20230626085957_B36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/dc20-0723","article-title":"Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?","volume":"43","author":"Sardu","year":"2020","unstructured":"36 Sardu C, D\u2019Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes Care. 2020;43(7):1408-15.","journal-title":"Diabetes Care"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T13:00:30Z","timestamp":1687784430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/is-elevated-blood-glucose-at-admission-associated-with-poor-outcomes-in-hospitalized-covid-19-patients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,21]]}},"alternative-id":["10.20945\/2359-3997000000649"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000649","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e000649"}}